Ga 68 Dotate PET imaging in Neuroendocrine Cancer
Monday, July 31, 2017 | CancerNeuroendocrine carcinoma is one of the rare types of cancer that has shown an increasing tendency in recent years. Often stomach, intestine and pancreas occur secondarily in the lung. They usually go slow, patients live with disease for too long without symptoms.
What is the indication of neuroendocrine cancer?
The diagnosis of neuroendocrine cancer is usually made incidentally. Patients suffer from digestive system complaints such as indigestion, gas, diarrhea and pain. Ultrasonography of the abdomen, MR, such as the examination occurs.
Does PET / CT work?
FDG PET / CT, which is normally used in the diagnosis and management of cancer, is not very sensitive to the diagnosis and staging of neuroendocrine cancers. PET / CT scintigraphy called Ga-68-DOTATATE should be performed for the diagnosis and staging of neuroendocrine cancers. Ga 68 DOTATATE PET CT is an indispensable imaging technique for the diagnosis of neuroendocrine cancers.
What is Ga-68 DOTATATE PET / CT?
Ga-68 DOTATATE PET / CT is the most advanced technology available for diagnosis of neuroendocrine tumors. In this method, a drug called a "smart molecule" that is given to a patient finds it in the body and sticks to it. Thanks to the intelligent molecules used, diseased areas are easily found. If the diagnosis of the disease is correct and accurate, treatment planning will be more accurate. In this method, the patient is not given high radiation dose. The given medication has no side effects. The patient feels nothing. The entire process is completed in 20 minutes.